Back to Search
MAREN ROWLEY, PHARMD
PHARMD
Pharmacist
NPI: 1659991867Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
5250122-1701(UT)
Research & Publications (20)
Discovery of a potent class I selective ketone histone deacetylase inhibitor with antitumor activity in vivo and optimized pharmacokinetic properties.
PMID 19441846·J Med Chem·2009
7-preclinical
Optimization of thienopyrrole-based finger-loop inhibitors of the hepatitis C virus NS5B polymerase.
PMID 19672916·ChemMedChem·2009
7-preclinical
Identification of aminoethyl pyrrolo dihydroisoquinolinones as novel poly(ADP-ribose) polymerase-1 inhibitors.
PMID 19553107·Bioorg Med Chem Lett·2009
8-other
Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model.
PMID 19410459·Bioorg Med Chem Lett·2009
7-preclinical
Discovery of N-[(1-aryl-1H-indazol-5-yl)methyl]amides derivatives as smoothened antagonists for inhibition of the hedgehog pathway.
PMID 19540115·Bioorg Med Chem Lett·2009
8-other
N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors.
PMID 19523819·Bioorg Med Chem Lett·2009
7-preclinical
Inhibitors of the hepatitis C virus NS3 protease with basic amine functionality at the P3-amino acid N-terminus: discovery and optimization of a new series of P2-P4 macrocycles.
PMID 19624135·J Med Chem·2009
7-preclinical
Metabolism-related liabilities of a potent histone deacetylase (HDAC) inhibitor and relevance of the route of administration on its metabolic fate.
PMID 19569735·Xenobiotica·2009
7-preclinical
Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
PMID 19541484·Bioorg Med Chem Lett·2009
8-other
Methylene blue-associated serotonin syndrome: a 'green' encephalopathy after parathyroidectomy.
PMID 19263250·Neurocrit Care·2009
5-case
Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture.
PMID 19216075·Bioorg Med Chem Lett·2009
8-other
Synthesis and evaluation of novel phosphoramidate prodrugs of 2'-methyl cytidine as inhibitors of hepatitis C virus NS5B polymerase.
PMID 19181520·Bioorg Med Chem Lett·2009
4-observational
Quantitative prediction of human clearance guiding the development of Raltegravir (MK-0518, isentress) and related HIV integrase inhibitors.
PMID 19144773·Drug Metab Dispos·2009
7-preclinical
Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase.
PMID 19131244·Bioorg Med Chem Lett·2009
7-preclinical
Guessing imagined and live chance events: adults behave like children with live events.
PMID 19079952·Br J Psychol·2009
8-other
Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine.
PMID 19493593·Eur J Med Chem·2009
7-preclinical
Microcephalin regulates BRCA2 and Rad51-associated DNA double-strand break repair.
PMID 19549900·Cancer Res·2009
8-other
Studies of the metabolic stability in cells of 5-(trifluoroacetyl)thiophene-2-carboxamides and identification of more stable class II histone deacetylase (HDAC) inhibitors.
PMID 18952417·Bioorg Med Chem Lett·2008
8-other
2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors.
PMID 18930398·Bioorg Med Chem Lett·2008
8-other
Optimization of a series of potent and selective ketone histone deacetylase inhibitors.
PMID 18809328·Bioorg Med Chem Lett·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 980 E FORT UNION BLVD
MIDVALE, UT 84047 - Phone
- (801) 671-4314
Quick Facts
- NPI
- 1659991867
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile